HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Phase II study of spirogermanium in advanced (extensive) non-small cell lung cancer.

AuthorsH M Dhingra, T Umsawasdi, D F Chiuten, W K Murphy, P Y Holoye, G Spitzer, M Valdivieso
JournalCancer treatment reports (Cancer Treat Rep) Vol. 70 Issue 5 Pg. 673-4 (May 1986) ISSN: 0361-5960 [Print] United States
PMID3708617 (Publication Type: Journal Article, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Antineoplastic Agents
  • Organometallic Compounds
  • Spiro Compounds
  • Germanium
  • spirogermanium
Topics
  • Adenocarcinoma (drug therapy)
  • Adult
  • Aged
  • Antineoplastic Agents (therapeutic use)
  • Carcinoma, Squamous Cell (drug therapy)
  • Drug Evaluation
  • Female
  • Germanium (therapeutic use)
  • Humans
  • Lung Neoplasms (drug therapy, pathology)
  • Male
  • Middle Aged
  • Neoplasm Staging
  • Organometallic Compounds
  • Spiro Compounds (therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: